CBD Global Sciences Inc.
CBDNFOTCHealthcare
$0.04
$-0.00(-2.67%)
Market Cap$2072232
P/E Ratio—
52W High$0.121
52W Low$0.016
CBD Global Sciences Inc.（CBDNF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CBDNF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|
| Revenue | |||
| Revenue | $0.17M | $0.31M | $2.32M |
| Cost of Revenue | $0.13M | $0.49M | $0.88M |
| Gross Profit | $0.04M | ($0.19M) | $1.43M |
| Gross Margin %(computed) | 24.56% | -61.25% | 61.85% |
| Operating Expenses | |||
| R&D Expenses | $0.01M | $0.04M | $0.07M |
| G&A Expenses | $1.91M | $2.11M | $2.86M |
| Total Operating Expenses | $2.73M | $2.39M | $3.75M |
| Operating Income | ($2.74M) | ($2.65M) | ($2.37M) |
| Operating Margin %(computed) | — | -868.53% | -102.19% |
| Interest Income | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.54M | $1.14M | $2.01M |
| Income Before Tax | ($5.20M) | ($8.93M) | ($9.07M) |
| Income Tax Expense | $0.59M | $0.00M | ($0.12M) |
| Net Income | ($5.25M) | ($8.93M) | ($8.96M) |
| Net Margin %(computed) | — | — | -386.52% |
| Per Share & EBITDA | |||
| EPS (Basic) | $-0.15 | $-0.28 | $-0.53 |
| Wtd Avg Shares | 35.68M | 31.50M | 16.84M |
| EBITDA | ($4.05M) | ($2.55M) | ($4.75M) |
| EBITDA Margin %(computed) | — | -833.64% | -205.00% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解CBD Global Sciences Inc.
关于CBD Global Sciences Inc.（CBDNF）损益表
CBD Global Sciences Inc.（CBDNF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2021财年，CBDNF实现营收$0.00B，毛利润$0.00B（毛利率24.56%），净利润($0.01B)（净利率-3146.33%）。
常见问题
CBDNF · 4 问CBD Global Sciences Inc.（CBDNF）2021财年营收为$0.00B，同比down45.3%。
CBDNF revenueCBDNF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09